A detailed history of Ensign Peak Advisors, Inc transactions in Novo Nordisk A S stock. As of the latest transaction made, Ensign Peak Advisors, Inc holds 783,737 shares of NVO stock, worth $65.9 Million. This represents 0.17% of its overall portfolio holdings.

Number of Shares
783,737
Previous 785,551 0.23%
Holding current value
$65.9 Million
Previous $112 Million 16.78%
% of portfolio
0.17%
Previous 0.21%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$119.07 - $145.42 $215,992 - $263,791
-1,814 Reduced 0.23%
783,737 $93.3 Million
Q2 2024

Aug 13, 2024

BUY
$122.71 - $146.91 $23.6 Million - $28.3 Million
192,541 Added 32.47%
785,551 $112 Million
Q1 2024

May 14, 2024

BUY
$102.11 - $135.92 $60.6 Million - $80.6 Million
593,010 New
593,010 $76.1 Million

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $190B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Ensign Peak Advisors, Inc Portfolio

Follow Ensign Peak Advisors, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ensign Peak Advisors, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ensign Peak Advisors, Inc with notifications on news.